Mumbai, June 21 : LifeCell International, an Indian stem cell banking pioneer, has introduced a range of self-collection testing and preservation kits under its reproductive, sexual, women’s and baby health services.
The testing kits are primarily aimed at encouraging testing for conditions that are often stigmatised and considered taboo.
“Infertility is a growing concern in India with 10 to 14 per cent of the population affected, according
to ISAR, and approximately 2.75 crore couples actively trying to conceive currently suffering from it. However, less than 1 per cent of infertile couples seek treatment, which translates to around 2,75,000 couples,” said Mayur Abhaya, Managing Director of LifeCell International.
“At LifeCell International, we help them to help plan for future dreams of parenthood by preservation services such as SpermVault & OvaVault,” said Abhaya.
In 2020, there were approximately 6,04,127 new cases of cervical cancer and 3,41,831 deaths globally, with India reporting around 21per cent of the total cervical cancer cases. Also a recent survey revealed that over 66 per cent of women with serious menopause issues .
Dr. Nandita Palshetkar, President of The Indian Society of Assisted Reproduction said, “this will ensure early detection of crucial ailments thereby enabling prompt medical intervention and
guidance at an early stage.
The pricing range of the kits starts from Rs 1,500 and goes up to Rs 60,000 , a statement issued
here stated on Wednesday.